OS Therapies Statistics
NYSE: OSTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.60+0.045 (+2.89%)
Market open · Delayed 15 min · as of Oct 8, 12:12 PM ET
OS Therapies by the numbers
OS Therapies has a market capitalization of $74.7 million based on 46.81M shares outstanding. With trailing EPS of $-1.08, OS Therapies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.1% below its 50-day average and 1.2% above its 200-day average.
Average daily trading volume is 597.09K shares, or about $952,357 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OSTX valuation vs. peer median
| Metric | OSTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $74.65M | $71.22M | +5% |
| Avg. volume | 597.09K | 511.70K | +17% |
Peer median across 8 companies: ONCY, NTHI, VRCA, GANX, MAIA, CING, PDSB, HRTX.
Valuation
- Market cap
- $74.65M
- Forward P/E
- 4.60
- EPS (TTM)
- $-1.08
- Shares outstanding
- 46.81M
Price and trading
- Previous close
- 1.55
- Open
- 1.55
- Day range
- 1.55 – 1.62
- 52-week range
- 1.15 – 2.25
- 52-week change
- -24.02%
- Beta
- —
- Volume
- 282.62K
- Average volume
- 597.09K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 17, 2026
Additional statistics
- Market Cap
- 74.65M
- Forward Pe
- 4.60
- Eps
- -1.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.25
- Week52 Low
- 1.15
- Avg Volume
- 597.09K
- Shares Outstanding
- 46.81M
- Ma50
- 1.65
- Ma200
- 1.58
- Earnings Date
- Aug 17, 2026
- Pct From52w High
- -29.11%
- Pct From52w Low
- 38.70%